Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
:HPC
Total Valuation
Hydration Pharmaceuticals Co. Ltd. has a market cap or net worth of AU$3.02M. The enterprise value is AU$572.13K.
Market CapAU$3.02M
Enterprise ValueAU$572.13K
Share Statistics
Hydration Pharmaceuticals Co. Ltd. has 430,800,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding430,800,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hydration Pharmaceuticals Co. Ltd.’s return on equity (ROE) is 0.97 and return on invested capital (ROIC) is -151.88%.
Return on Equity (ROE)0.97
Return on Assets (ROA)0.53
Return on Invested Capital (ROIC)-151.88%
Return on Capital Employed (ROCE)-1.52
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.64
Inventory Turnover1.45
Valuation Ratios
The current PE Ratio of Hydration Pharmaceuticals Co. Ltd. is ―. Hydration Pharmaceuticals Co. Ltd.’s PEG ratio is -0.00346.
PE Ratio―
PS Ratio0.44
PB Ratio0.51
Price to Fair Value0.51
Price to FCF-0.46
Price to Operating Cash Flow-1.34
PEG Ratio-0.00346
Income Statement
In the last 12 months, Hydration Pharmaceuticals Co. Ltd. had revenue of 3.20M and earned 2.67M in profits. Earnings per share was 0.02.
Revenue3.20M
Gross Profit1.62M
Operating Income-4.20M
Pretax Income-5.67M
Net Income2.67M
EBITDA-3.91M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was -1.64M and capital expenditures 0.00, giving a free cash flow of -1.64M billion.
Operating Cash Flow-1.64M
Free Cash Flow-1.64M
Free Cash Flow per Share>-0.01
Dividends & Yields
Hydration Pharmaceuticals Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.87
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)45.82
Average Volume (3m)1.21M
Important Dates
Hydration Pharmaceuticals Co. Ltd. upcoming earnings date is Mar 2, 2026, Before Open (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 2, 2026
Ex-Dividend Date―
Financial Position
Hydration Pharmaceuticals Co. Ltd. as a current ratio of 2.24, with Debt / Equity ratio of 0.00%
Current Ratio2.24
Quick Ratio1.75
Debt to Market Cap0.00
Net Debt to EBITDA0.82
Interest Coverage Ratio-2.38
Taxes
In the past 12 months, Hydration Pharmaceuticals Co. Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hydration Pharmaceuticals Co. Ltd. EV to EBITDA ratio is 0.47, with an EV/FCF ratio of 0.60.
EV to Sales-0.57
EV to EBITDA0.47
EV to Free Cash Flow0.60
EV to Operating Cash Flow0.60
Balance Sheet
Hydration Pharmaceuticals Co. Ltd. has AU$2.11M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$2.11M billion.
Cash & Marketable SecuritiesAU$2.11M
Total DebtAU$0.00
Net CashAU$2.11M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is 105.27%, with operating margin of -130.95%, and net profit margin of 83.23%.
Gross Margin105.27%
Operating Margin-130.95%
Pretax Margin-177.05%
Net Profit Margin83.23%
EBITDA Margin-122.02%
EBIT Margin-122.02%
Analyst Forecast
The average price target for Hydration Pharmaceuticals Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―